Versant Voyageurs I, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 16,061 shares at $33.30 ($535K) on 2020-10-26, disclosed to the SEC on 2020-10-28.
Scheduled sale ($535k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.30 | 945 | $31K | 5.9% |
| 2 | $33.30 | 7,158 | $238K | 44.6% |
| 3 | $33.30 | 7,158 | $238K | 44.6% |
| 4 | $33.03 | 93 | $3K | 0.6% |
| 5 | $33.03 | 707 | $23K | 4.4% |
| Total | $33.29 avg | 16,061 |
| $535K |
| 100% |
| Filing → |